Founded in 1970, PROBIOMED specializes in chemically synthesized and biosimilar generics, including cytokines, monoclonal antibodies, fusion proteins, and recombinant vaccines. Their products are aimed at preventing and treating autoimmune and chronic-degenerative diseases, hematological and metabolic disorders, providing affordable high-tech solutions for improving health and quality of life.